APA (7th ed.) Citation

Hanfstein, B., Hofmann, W., Müller, M. C., Westhoff, N. C., Hehlmann, R., Saußele, S., . . . Dengler, J. (2014). A two-fold rise of BCR-ABL transcript levels advises BCR-ABL mutation analysis in imatinib-treated chronic myeloid leukemia (CML): An analysis of the randomized CML-study IV. Blood, 124(21), .

Chicago Style (17th ed.) Citation

Hanfstein, Benjamin, et al. "A Two-fold Rise of BCR-ABL Transcript Levels Advises BCR-ABL Mutation Analysis in Imatinib-treated Chronic Myeloid Leukemia (CML): An Analysis of the Randomized CML-study IV." Blood 124, no. 21 (2014).

MLA (9th ed.) Citation

Hanfstein, Benjamin, et al. "A Two-fold Rise of BCR-ABL Transcript Levels Advises BCR-ABL Mutation Analysis in Imatinib-treated Chronic Myeloid Leukemia (CML): An Analysis of the Randomized CML-study IV." Blood, vol. 124, no. 21, 2014.